V-Lab
Apimeds Pharmaceutica US Inc Asymmetric ILLIQ Liquidity Analysis
High-persistence model: shocks decay very slowly, so the theoretical long-run value may not be practically meaningful
Illiquidity prediction for Monday, August 3rd, 2026
1 Day
639,997.40
decreased by 59,028.50
1 Week
697,906.40
decreased by 1,119.50
1 Month
690,433.41
decreased by 8,592.49
Analysis last updated: Friday, July 31, 2026 at 11:08 PM UTC
News Impact Curve
How returns affect tomorrow's illiquidityIlliquidity Forecast
How illiquidity evolves over timeParameter Estimates
May 9, 2025 to Jul 31, 2026Model Insight
With persistence 1.000, illiquidity shocks have a half-life of 1386294 trading days (~5501.2 years), close to a unit root, so long-run forecasts are highly sensitive to this estimate.
μ
ILLIQ-AMEM Model
Tap to view equation
| Parameter | Value | t-statistic |
|---|---|---|
ω const Unconditional variance weight | 5.0000 | 0.00 |
α ARCH Response to squared shocks | 0.1122 | 3.31*** |
β GARCH Volatility persistence | 0.8892 | 52.10*** |
γ leverage Additional response to negative shocks | -0.0028 | -0.04 |
Persistence:
1.000
Half-life:
1386294 days
Other Apimeds Pharmaceutica US Inc Analyses
Other Asymmetric ILLIQ Analyses on Equities